SLNO - Soleno Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$80.00
DETAILS
HIGH:
$107.00
LOW:
$53.00
MEDIAN:
$80.00
CONSENSUS:
$80.00
UPSIDE:
50.91%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 98.6% |
| EBIT Margin | 13.8% |
| EBITDA Margin | 14.9% |
| Operating Margin | 7.9% |
| Pretax Margin | 11.0% |
| Cont. Ops Margin | 11.0% |
| Net Margin | 11.0% |
| Bottom Line Margin | 10.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.80 |
| Quick Ratio | 5.55 |
| Solvency Ratio | 0.201 |
| Cash Ratio | 1.14 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | -1.08 |
| Forward PEG | -1.08 |
| Price/Book | 5.47 |
| Price/Sales | 12.93 |
| Price/FCF | 52.69 |
| Price/Op Cash Flow | 52.61 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0048 |
| Debt/Equity | 0.0060 |
| Debt/Capital | 0.0059 |
| Long-Term Debt/Capital | 0.0043 |
| Financial Leverage | 1.25 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.67 |
| Operating Cash Flow Ratio | 0.763 |
| Operating Cash Flow/Sales | 24.6% |
| Free Cash Flow/Operating Cash Flow | 99.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 4.58 |
| Interest Coverage | 2.7301 |
| Short-Term Operating Cash Flow Coverage | 64.46 |
| Operating Cash Flow Coverage | 17.40 |
| Capital Expenditure Coverage | 641.07 |
| Dividend + Capital Expenditure Coverage | 641.07 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 3.58 |
| EPS | 0.393 |
| Debt/Share | 0.1536 |
| Cash/Share | 5.74 |
| Book Value/Share | 8.46 |
| Tangible BV/Share | 8.37 |
| Equity/Share | 8.46 |
| Operating Cash Flow/Share | 0.880 |
| Capital Expenditure/Share | 0.001 |
| FCF/Share | 0.879 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.397 |
| Price/Fair Value | 5.47 |
| Debt/Market Cap | 0.0011 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | 84.37 |